全球下一代测序数据分析市场 – 行业趋势和 2030 年预测

 下一代测序数据分析市场分析和规模

NHGRI 发起的未确诊疾病计划 (UDN) 使用 DNA 测序来发现罕见疾病的病因。而美国国家癌症研究所和 NHGRI 合作开展癌症基因组图谱项目，该项目使用 DNA 测序来研究 30 种癌症类型的基因组模式。正在进行和计划中的基因组测序项目预计将推动下一代测序数据分析市场的发展。

Data Bridge Market Research 分析，下一代测序数据分析市场在 2022 年的规模为 7.7846 亿美元，预计到 2030 年将达到 26.7794 亿美元，在 2023 年至 2030 年的预测期内复合年增长率为 16.7%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

下一代测序数据分析市场范围和细分

Market Definition

NGS, also known as high throughput sequencing, is a term that refers to a number of advanced sequencing technologies. Researchers can investigate biological processes in depth for next-generation sequencing's high throughput, scalability, and speed. A higher level of understanding than that provided by traditional DNA sequencing methods is now required because of the complexities involved in genomic science.

Global Next Generation Sequencing Data Analysis Market Dynamics

Drivers

• Rising research and development activities

Globally, major corporations have increased their capacity for research and development. During the pandemic, the heavy emphasis on COVID-19 vaccine development provided a lucrative opportunity for NGS adoption. For instance, a group of Chinese researchers sequenced COVID-19 samples using the Oxford Nanopore Technologies (UK) product MinION Mk1C. Furthermore, factors such as widespread adoption of NGS technologies in clinical diagnostics due to faster results and processing are expected to provide a favourable environment for market growth during the forecast period.

• Rise in use of clinical diagnosis

The advancement of next-generation sequencing (NGS) technologies and their increasing use in clinical diagnosis, genomic research, and personalised medicine for a variety of diseases is increasing the demand for accurate and fast sequencing interpretation tools and algorithms that can speed up data analysis. Furthermore, as the amount of genetic data produced grows and sequencing costs fall, the size of sequencing projects is expected to grow. As a result, there is a greater demand for complex bioinformatics pipelines with cutting-edge, effective solutions.

Opportunities

• Technological advancements

Growing technological advances in NGS instruments and technologies are expected to drive significant market growth in the coming years. For instance, the Intelligence Advanced Research Projects Activity in the United States awarded a USD 23 million grant to Harvard University, DNA Script, and the Broad Institute in January 2020. The institutes are working together to create a new technology that will combine enzymatic DNA synthesis and NGS into a single instrument.

Restraints/Challenges

• High cost

The cost of infrastructural development for algorithms and software is expected to limit market growth to some extent. In the forecast period, a lack of skilled personnel will act as a restraint, further challenging the growth of the next generation sequencing data analysis market.

Furthermore, the time-consuming nature of NGS data analysis is impeding market growth.

This next generation sequencing data analysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the next generation sequencing data analysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Next Generation Sequencing Data Analysis Market

COVID-19 began to spread throughout the world in early 2020, infecting millions of people. Major nations around the world have now endorsed restrictions and work stoppage orders. With the exception of those manufacturing medical supplies and life support equipment, the majority of businesses have suffered significant damage. Next-generation sequencing data analysis industries have also been severely impacted. As a result of the COVID-19 outbreak, NGS usage has skyrocketed, and there is now a sizable market for NGS data analysis tools. The NGS technologies were able to generate a large amount of data for the purpose of studying and analysing pathogenesis. Sequencing has been used by experts from academia, business, and government to aid in the study of SARS-CoV2 traits, procedures, and phylogenetics.

Recent Developments

•  In 2021, Cerba Research announced the launch of new tools to improve R&D for vaccine development against infectious diseases, including COVID-19.
• In 2021, Swift Biosciences, a pioneer in the development of NGS library preparation genomics kits for clinical, translational, and academic research, was acquired by Integrated DNA Technologies (IDT).

Global Next Generation Sequencing Data Analysis Market Scope

The next generation sequencing data analysis market is segmented on the basis of product, workflow, mode, read length and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Services
• NGS Commercial Software
• Platform OS/UI
• Analytical Software
• QC/Pre-processing Tools
• Alignment Tools and Software
• DNA Seq Alignment
• RNA Seq Alignment
• Protein Seq Alignment
• Others

Workflow

• Primary
• Secondary
• Read Mapping
• Variant Alignment and Variant Calling
• Tertiary
• Variant Annotation
• Application Specific
• Targeted Sequencing/Gene Panel
• Exome
• RNA Seq
• Whole Genome
• Chip Seq
• Others

Mode

• In-house
• Outsourced

Read Length

• 长读测序
• 短读测序
• 超长读长测序

终端用户

• 学术研究
• 临床研究
• 医院和诊所
• 制药和生物技术实体
• 其他用户

下一代测序数据分析市场区域分析/见解

对下一代测序数据分析市场进行了分析，并按国家、产品、工作流程、模式、读取长度和最终用户提供了市场规模洞察和趋势。

下一代测序数据分析市场报告涵盖的国家包括北美的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区（APAC）的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区（APAC）的其他地区、中东和非洲（MEA）的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于测序平台的技术进步和该地区 NGS 应用的兴起，北美在下一代测序数据分析市场中占据主导地位。

预计亚太地区将在 2023 年至 2030 年的预测期内实现最高增长率，因为该地区发展中国家获得的测序项目资助数量不断增加。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

下一代测序数据分析市场还为您提供每个国家/地区资本设备医疗保健支出增长、下一代测序数据分析市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对下一代测序数据分析市场的影响的详细市场分析。数据涵盖 2011-2021 年的历史时期。

竞争格局和下一代测序数据分析市场份额分析

下一代测序数据分析市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对下一代测序数据分析市场的关注有关。

下一代测序数据分析市场的一些主要参与者包括：

• 赛默飞世尔科技公司（美国）
• QIAGEN（德国）
• Illumina 公司（美国）
• F. Hoffmann-La Roche Ltd.（瑞士）
• 安捷伦科技公司（美国）
• Bio-Rad Laboratories, Inc.（美国）
• 皮尔语（印度）
• Precigen（德国）
• Partek Incorporated（美国）
• Eurofins Scientific（卢森堡）
• PacBio (美国)
• DNASTAR（美国）
• Congenica Ltd.（英国）
• Fabric Genomics, Inc.（美国）
• DNAnexus Inc.（美国）

SKU-56434